Pharma Focus Asia

Solvias Plans to Open New Biotech Site in California, USA

Introduction:

Solvias plans to expand its global network to build a new biotech site in North California, USA. 

Features: 

The new 50,000-square-foot facility will expand analytical testing services for life science organisations, addressing the growing use and development of cell and gene therapies (CGTs) and biologics.

This state-of-the-art centre will offer crucial cell-based potency assays, advanced next-gen sequencing (NGS) capabilities, and a variety of related testing services supporting multiple biologic modalities. 

From its inception, it will facilitate the characterisation and release testing of CGTs and other advanced therapies, including adeno-associated virus (AAV) gene therapies, mRNA therapies, and antibody-drug conjugates.

The new centre will be equipped with state-of-the-art analytical instrumentation, advanced laboratory automation technology, and integrated digital management systems.

The new facility is expected to be completed in 2025. It will create over 170 serving as hub for large molecule analytical services.

Specifications:

Name    Solvias
Type      New Construction
Year       2025


 

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference